Literature DB >> 28444415

[Conventional radiological diagnosis of benign none neoplasms].

A Bücker1, G Schneider2.   

Abstract

BACKGROUND: Benign bone tumors are of special clinical importance because they might be confused with malignant bone tumors.
OBJECTIVES: The aim of this article it to present the characteristics of benign bone tumors. The focus is orientated towards conventional x‑ray as the essential pillar for primary diagnosis. Consequently, the description of signal intensities of benign bone tumors in magnetic resonance images or less helpful clues like male-female ratios are deliberately omitted.
RESULTS: The classification of bone tumors introduced by Lodwick allows the identification of benign growth patterns. Growth patterns will not help, for example, in case of dedifferentiation of benign chondroid tumors towards chondrosarcomas. Therefore, each diagnosis has to incorporate the patient's clinical scenario. Furthermore, benign bone tumors might also cause aggressive growth patterns. Tumors classified as Lodwick Ic or higher should not be automatically regarded as malignant. Naturally, further clarification is mandatory for these tumors.
CONCLUSIONS: Differentiation between definitely benign bone tumors and those which need further work up is a critical diagnostic step. In the majority of cases, this is possible based on the appearance in conventional x‑ray images. In case of possibly malignant lesions, both the patient's symptoms and the x‑ray morphology have to be considered by orthopedic surgeons, pathologists, and radiologists to determine the optimal diagnostic strategy.

Entities:  

Keywords:  Bone lesion; Chondroid tumors; Growth patterns; Lodwick classification; Radiology

Mesh:

Year:  2017        PMID: 28444415     DOI: 10.1007/s00132-017-3424-4

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  10 in total

Review 1.  Imaging and differential diagnosis of primary bone tumors and tumor-like lesions of the spine.

Authors:  R Erlemann
Journal:  Eur J Radiol       Date:  2006-01-20       Impact factor: 3.528

2.  Tumors of the rib.

Authors:  H Zarqane; P Viala; B Dallaudière; H Vernhet; C Cyteval; A Larbi
Journal:  Diagn Interv Imaging       Date:  2013-09-03       Impact factor: 4.026

3.  Determining growth rates of focal lesions of bone from radiographs.

Authors:  G S Lodwick; A J Wilson; C Farrell; P Virtama; F Dittrich
Journal:  Radiology       Date:  1980-03       Impact factor: 11.105

4.  Estimating rate of growth in bone lesions: observer performance and error.

Authors:  G S Lodwick; A J Wilson; C Farrell; P Virtama; F M Smeltzer; F Dittrich
Journal:  Radiology       Date:  1980-03       Impact factor: 11.105

Review 5.  Benign primary tumours of the ribs.

Authors:  E K Hughes; S L J James; S Butt; A M Davies; A Saifuddin
Journal:  Clin Radiol       Date:  2006-04       Impact factor: 2.350

Review 6.  An imaging overview of primary tumors of the spine: Part 1. Benign tumors.

Authors:  Daphne J Theodorou; Stavroula J Theodorou; David J Sartoris
Journal:  Clin Imaging       Date:  2008 May-Jun       Impact factor: 1.605

7.  [Determination of the growth rate of tumor-like space-occupying lesions of the bones. A study of 1154 lesions of the long tubular bones].

Authors:  R Erlemann; G Edel; A Roessner; H Müller-Miny
Journal:  Radiologe       Date:  1994-02       Impact factor: 0.635

8.  Interobserver Variability in the Differential Diagnosis of Benign Bone Tumors and Tumor-like Lesions.

Authors:  P Scheitza; M Uhl; O Hauschild; J Zwingmann; H Bannasch; C Kayser; N P Südkamp; G W Herget
Journal:  Rofo       Date:  2016-01-27

Review 9.  Imaging review of skeletal tumors of the pelvis--part I: benign tumors of the pelvis.

Authors:  Gandikota Girish; Karen Finlay; Yoav Morag; Catherine Brandon; Jon Jacobson; David Jamadar
Journal:  ScientificWorldJournal       Date:  2012-05-15

Review 10.  Primary tumors of the patella.

Authors:  Mingzhi Song; Zhen Zhang; Yuxuan Wu; Kai Ma; Ming Lu
Journal:  World J Surg Oncol       Date:  2015-04-25       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.